Mangoceuticals’ Merger Partner, Nuclea Energy, Enters Into Definitive Agreement With Moltex Energy To Acquire Advanced Nuclear Technology Assets; Terms Undisclosed
The acquisition of Moltex brings over a decade of advanced nuclear R&D, backed by more than C$96 million in private investment and public funding from Canada and the U.S. Department of Energy.Asset-led transaction
Mangoceuticals' partner company is buying nuclear technology that scientists have spent over ten years developing. This shows the company is investing in new tools, which you can watch to see if it helps them grow in the future.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.